Affordable Access

deepdyve-link
Publisher Website

Withdrawn: The novel TRPA1 antagonist BI01305834 inhibits ovalbumin-induced bronchoconstriction in guinea pigs.

Authors
  • van den Berg, Mariska1, 2
  • Nijboer-Brinksma, Susan1, 2
  • Bos, Sophie1, 2
  • van den Berge, Maarten2, 3
  • Lamb, David4
  • van Faassen, Martijn5
  • Kema, Ido5
  • Gosens, Reinoud1, 2
  • Kistemaker, Loes1, 2
  • 1 Department of Molecular Pharmacology, University of Groningen, Groningen, The Netherlands. , (Netherlands)
  • 2 Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. , (Netherlands)
  • 3 Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. , (Netherlands)
  • 4 Immunology and Respiratory, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany. , (Germany)
  • 5 Department of Laboratory Medicine, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands. , (Netherlands)
Type
Published Article
Journal
British Journal of Pharmacology
Publisher
Wiley (Blackwell Publishing)
Publication Date
Oct 01, 2020
Volume
177
Issue
20
Pages
4809–4809
Identifiers
DOI: 10.1111/bph.15133
PMID: 32436213
Source
Medline
Language
English
License
Unknown

Abstract

The above article from the British Journal of Pharmacology, published online on May 20, 2020 in Wiley Online Library (http://wileyonlinelibrary.com) has been withdrawn due to a lack of full disclosure of the chemical structure of the novel TRPA1 antagonist BI01305834, by agreement between the Editor-in-Chief and John Wiley & Sons Inc on behalf of The British Pharmacology Society. © 2020 The British Pharmacological Society.

Report this publication

Statistics

Seen <100 times